Louisa M.S. Gerhardt

2.9k total citations · 2 hit papers
19 papers, 1.8k citations indexed

About

Louisa M.S. Gerhardt is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Nephrology. According to data from OpenAlex, Louisa M.S. Gerhardt has authored 19 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Nephrology. Recurrent topics in Louisa M.S. Gerhardt's work include Renal and related cancers (5 papers), Heart Failure Treatment and Management (5 papers) and Acute Kidney Injury Research (4 papers). Louisa M.S. Gerhardt is often cited by papers focused on Renal and related cancers (5 papers), Heart Failure Treatment and Management (5 papers) and Acute Kidney Injury Research (4 papers). Louisa M.S. Gerhardt collaborates with scholars based in United States, Germany and Switzerland. Louisa M.S. Gerhardt's co-authors include Matthias Nahrendorf, Filip K. Świrski, Yoshiko Iwamoto, Ralph Weissleder, Ingo Hilgendorf, Peter Libby, Georg F. Weber, Clinton S. Robbins, Igor Theurl and Andrew P. McMahon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Nature Medicine.

In The Last Decade

Louisa M.S. Gerhardt

18 papers receiving 1.8k citations

Hit Papers

Local proliferation dominates lesional macrophage accumul... 2013 2026 2017 2021 2013 2014 250 500 750

Peers

Louisa M.S. Gerhardt
Roslynn A. Stirzaker United States
George Stavrakis United States
Amanda C. Foks Netherlands
Michael Tencati United States
Roslynn A. Stirzaker United States
Louisa M.S. Gerhardt
Citations per year, relative to Louisa M.S. Gerhardt Louisa M.S. Gerhardt (= 1×) peers Roslynn A. Stirzaker

Countries citing papers authored by Louisa M.S. Gerhardt

Since Specialization
Citations

This map shows the geographic impact of Louisa M.S. Gerhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louisa M.S. Gerhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louisa M.S. Gerhardt more than expected).

Fields of papers citing papers by Louisa M.S. Gerhardt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louisa M.S. Gerhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louisa M.S. Gerhardt. The network helps show where Louisa M.S. Gerhardt may publish in the future.

Co-authorship network of co-authors of Louisa M.S. Gerhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Louisa M.S. Gerhardt. A scholar is included among the top collaborators of Louisa M.S. Gerhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louisa M.S. Gerhardt. Louisa M.S. Gerhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Polonsky, Michal, Louisa M.S. Gerhardt, Jina Yun, et al.. (2024). Spatial transcriptomics defines injury specific microenvironments and cellular interactions in kidney regeneration and disease. Nature Communications. 15(1). 7010–7010. 25 indexed citations
2.
Angermann, Christiane E., Susanne Sehner, Louisa M.S. Gerhardt, et al.. (2024). Anaemia predicts iron homoeostasis dysregulation and modulates the response to empagliflozin in heart failure with reduced ejection fraction: the EMPATROPISM-FE trial. European Heart Journal. 46(16). 1507–1523. 6 indexed citations
3.
Gerhardt, Teresa, Louisa M.S. Gerhardt, Wouter Ouwerkerk, et al.. (2023). Multimorbidity in patients with acute heart failure across world regions and country income levels (REPORT-HF): a prospective, multicentre, global cohort study. The Lancet Global Health. 11(12). e1874–e1884. 19 indexed citations
4.
Angermann, Christiane E., Carlos G. Santos‐Gallego, Juan Antonio Requena-Ibáñez, et al.. (2023). Empagliflozin effects on iron metabolism as a possible mechanism for improved clinical outcomes in non-diabetic patients with systolic heart failure. Nature Cardiovascular Research. 2(11). 1032–1043. 33 indexed citations
5.
Gerhardt, Louisa M.S., Kari Koppitch, Jordi van Gestel, et al.. (2023). Lineage Tracing and Single-Nucleus Multiomics Reveal Novel Features of Adaptive and Maladaptive Repair after Acute Kidney Injury. Journal of the American Society of Nephrology. 34(4). 554–571. 54 indexed citations
6.
Gerhardt, Louisa M.S., Susanne Sehner, Gülmisal Güder, et al.. (2022). Prevalence and prognostic impact of chronic kidney disease and anaemia across ACC/AHA precursor and symptomatic heart failure stages. Clinical Research in Cardiology. 112(7). 868–879. 7 indexed citations
7.
Gerhardt, Louisa M.S. & Andrew P. McMahon. (2022). Identifying Common Molecular Mechanisms in Experimental and Human Acute Kidney Injury. Seminars in Nephrology. 42(3). 151286–151286. 9 indexed citations
8.
Gerhardt, Louisa M.S. & Andrew P. McMahon. (2021). Multi-omic approaches to acute kidney injury and repair. Current Opinion in Biomedical Engineering. 20. 100344–100344. 14 indexed citations
9.
Gerhardt, Louisa M.S., Jing Liu, Kari Koppitch, Pietro E. Cippà, & Andrew P. McMahon. (2021). Single-nuclear transcriptomics reveals diversity of proximal tubule cell states in a dynamic response to acute kidney injury. Proceedings of the National Academy of Sciences. 118(27). 131 indexed citations
10.
11.
Gerhardt, Louisa M.S., et al.. (2020). Paraneoplastisches Cushing-Syndrom als Ursache von therapierefraktärer Hypokaliämie. DMW - Deutsche Medizinische Wochenschrift. 145(11). 783–786. 2 indexed citations
12.
Gerhardt, Louisa M.S. & Christiane E. Angermann. (2019). Hyperkaliämie. DMW - Deutsche Medizinische Wochenschrift. 144(22). 1576–1584. 4 indexed citations
13.
Gerhardt, Louisa M.S., et al.. (2019). Comparison of Acuseal and Standard ePTFE Vascular Grafts for Hemodialysis: A Retrospective Case Series. 12(1). 4–8. 3 indexed citations
14.
Weber, Georg F., Benjamin G. Chousterman, Ingo Hilgendorf, et al.. (2014). Pleural innate response activator B cells protect against pneumonia via a GM-CSF-IgM axis. The Journal of Experimental Medicine. 211(6). 1243–1256. 121 indexed citations
15.
Hilgendorf, Ingo, Igor Theurl, Louisa M.S. Gerhardt, et al.. (2014). Innate Response Activator B Cells Aggravate Atherosclerosis by Stimulating T Helper-1 Adaptive Immunity. Circulation. 129(16). 1677–1687. 107 indexed citations
16.
Hilgendorf, Ingo, Louisa M.S. Gerhardt, Timothy C. Tan, et al.. (2014). Ly-6C high Monocytes Depend on Nr4a1 to Balance Both Inflammatory and Reparative Phases in the Infarcted Myocardium. Circulation Research. 114(10). 1611–1622. 439 indexed citations breakdown →
17.
Robbins, Clinton S., Ingo Hilgendorf, Georg F. Weber, et al.. (2013). Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nature Medicine. 19(9). 1166–1172. 779 indexed citations breakdown →
18.
Schwartsmann, Gilberto, Eduardo Sprinz, Luciane Kalakun, et al.. (1997). Clinical and pharmacokinetic study of oral etoposide in patients with AIDS-related Kaposi's sarcoma with no prior exposure to cytotoxic therapy.. Journal of Clinical Oncology. 15(5). 2118–2124. 24 indexed citations
19.
Schwartsmann, Gilberto, et al.. (1997). Decitabine (5-Aza-2'-deoxycytidine; DAC) plus daunorubicin as a first line treatment in patients with acute myeloid leukemia: preliminary observations.. PubMed. 11 Suppl 1. S28–31. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026